Filing Signals

Source: SEC EDGAR Compiled 2026-11-13 17:17 UTC 23 automated checks passing

← All events

LifeMD, Inc.

CIK 948320 LFMD·Services · All EDGAR filings ↗

Progression

  1. Finance chief departure 8-K
  2. Late filing NT 10-Q +236d
Refine
Form
An amendment is grouped with the report it amends; every 12b-25 notice is one group

Late filing Filing comparison

LifeMD, Inc. told the SEC it could not file its quarterly report on time

Does not expect a significant change in results. Filed 5 days before the statutory due date.

(the “Company”) has determined that it is unable to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2026 (the “Form 10-Q”) by November 9, 2026, the original due date for such filing, without unreasonable effort or expense because it requires additional time to complete its financial statements. The Company requires additional time to finalize adjustments necessary to correct the over recognition of revenue and under recognition of cost of revenue and general and administrative expenses that the Company identified. The adjustments related to the Company’s historical financial statements for quarterly and annual periods between 2024 and June 30, 2026. The required…
Evidence
Anticipates significant change
No
Days past due date
-5
Other periodic reports filed
Yes
Routine
Yes
Severity
normal
Source
Form 12b-25 (notification of late filing)
Stated reason
(the “Company”) has determined that it is unable to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2026 (the “Form 10-Q”) by November 9, 2026, the original due date for such filing, without unreasonable effort or expense because it requires additional time to complete its financial statements. The Company requires additional time to finalize adjustments necessary to correct the over recognition of revenue and under recognition of cost of revenue and general and administrative expenses that the Company identified. The adjustments related to the Company’s historical financial statements for quarterly and annual periods between 2024 and June 30, 2026. The required…
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.
Finance chief departure elevated Filing comparison

LifeMD, Inc.'s Chief Financial Officer departed, replaced on an interim basis

Evidence
Interim only
Yes
Item code
5.02
Item title
Departure of Directors or Certain Officers
Role
Chief Financial Officer
Severity
elevated
Source
SEC 8-K item code
Successor named
No
Why
The company's chief financial or accounting officer departed, disclosed under 8-K Item 5.02.